Suppr超能文献

干预措施以减少儿童腹泻病的急性后后果:系统评价。

Interventions to reduce post-acute consequences of diarrheal disease in children: a systematic review.

机构信息

Department of Global Health, University of Washington, Seattle, WA, USA.

Department of Epidemiology, University of Washington, Seattle, WA, USA.

出版信息

BMC Public Health. 2018 Feb 1;18(1):208. doi: 10.1186/s12889-018-5092-7.

Abstract

BACKGROUND

Although acute diarrhea often leads to acute dehydration and electrolyte imbalance, children with diarrhea also suffer long term morbidity, including recurrent or prolonged diarrhea, loss of weight, and linear growth faltering. They are also at increased risk of post-acute mortality. The objective of this systematic review was to identify interventions that address these longer term consequences of diarrhea.

METHODS

We searched Medline for randomized controlled trials (RCTs) of interventions conducted in low- and middle-income countries, published between 1980 and 2016 that included children under 15 years of age with diarrhea and follow-up of at least 7 days. Effect measures were summarized by intervention. PRISMA guidelines were followed.

RESULTS

Among 314 otherwise eligible RCTs, 65% were excluded because follow-up did not extend beyond 7 days. Forty-six trials were included, the majority of which (59%) were conducted in Southeast Asia (41% in Bangladesh alone). Most studies were small, 76% included less than 200 participants. Interventions included: therapeutic zinc alone (28.3%) or in combination with vitamin A (4.3%), high protein diets (19.6%), probiotics (10.9%), lactose free diets (10.9%), oral rehydration solution (ORS) formulations (8.7%), dietary supplements (6.5%), other dietary interventions (6.5%), and antimicrobials (4.3%). Prolonged or recurrent diarrhea was the most commonly reported outcome, and was assessed in ORS, probiotic, vitamin A, and zinc trials with no consistent benefit observed. Seven trials evaluated mortality, with follow-up times ranging from 8 days to 2 years. Only a single trial found a mortality benefit (therapeutic zinc). There were mixed results for dietary interventions affecting growth and diarrhea outcomes in the post-acute period.

CONCLUSION

Despite the significant post-acute mortality and morbidity associated with diarrheal episodes, there is sparse evidence evaluating the effects of interventions to decrease these sequelae. Adequately powered trials with extended follow-up are needed to identify effective interventions to prevent post-acute diarrhea outcomes.

摘要

背景

虽然急性腹泻常导致急性脱水和电解质失衡,但腹泻患儿还会长期发病,包括反复发作或持续性腹泻、体重减轻和线性生长迟缓。他们还面临更高的急性后期死亡风险。本系统评价的目的是确定可解决腹泻这些长期后果的干预措施。

方法

我们检索了 Medline 中发表于 1980 年至 2016 年间的在低收入和中等收入国家进行的、针对 15 岁以下腹泻患儿且随访期至少 7 天的随机对照试验(RCT)。通过干预措施总结效应量。本研究遵循 PRISMA 指南。

结果

在 314 项符合条件的 RCT 中,有 65%因随访期未超过 7 天而被排除。46 项试验被纳入,其中大多数(59%)来自东南亚(仅孟加拉国占 41%)。大多数研究规模较小,76%的研究纳入的参与者少于 200 人。干预措施包括:单独使用治疗性锌(28.3%)或与维生素 A 联合使用(4.3%)、高蛋白饮食(19.6%)、益生菌(10.9%)、无乳糖饮食(10.9%)、口服补液盐(ORS)配方(8.7%)、膳食补充剂(6.5%)、其他膳食干预(6.5%)和抗生素(4.3%)。迁延性或复发性腹泻是最常报告的结局,在 ORS、益生菌、维生素 A 和锌的试验中评估,但未观察到一致的获益。有 7 项试验评估了死亡率,随访时间从 8 天到 2 年不等。仅有一项试验发现了死亡率的获益(治疗性锌)。在急性后期影响生长和腹泻结局的膳食干预方面,结果存在差异。

结论

尽管腹泻发作会导致严重的急性后期死亡和发病,但几乎没有证据评估减少这些后果的干预措施的效果。需要开展有足够效能且随访时间延长的试验,以确定预防急性后期腹泻结局的有效干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/5796301/d33f27b927cb/12889_2018_5092_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验